Loading...
Loading...
- Universal Health Services Inc UHS, an acute care hospital and health care facility operator, posted Q2 2021 adjusted EPS of $3.76, which surpassed the consensus of $2.68, up 28% Y/Y than $2.93 a year ago.
- The company added that it saw robust recoveries in patient volumes at its acute care and behavioral health care hospitals compared to Q2 2020.
- However, the company cautioned that developments related to COVID-19 could have a material impact on financial results for the rest of the year.
- Sales for the quarter increased 17% Y/Y to $3.2billion, beating the estimate of $3.1 billion.
- Acute care hospitals owned during both periods (same facility basis), adjusted admissions (adjusted for outpatient activity) increased 26.4%, and adjusted patient days increased 21.6% Y/Y.
- At behavioral health care facilities on a same facility basis, adjusted admissions increased 14.1%, and adjusted patient days increased 7.4%.
- Universal Health Services authorized a $1 billion increase to the stock repurchase program to $3.7 billion.
- FY21 Outlook: Universal raised forecasted 2021 net revenues to $12.35B to $12.50 billion ($12.3B consensus) compared to the prior $12.10 billion - $12.40 billion.
- It expects adjusted EPS of $11.46-$12.16 ($11 consensus), higher than the previous guidance of $10.05-$11.05.
- UHS increased the expected adjusted EBITDA to $1.88B-$1.96B.
- Price Action: UHS shares closed at $154.61 on Monday.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in